← Leaderboards
Daniel Sanghoon Shin
Va Greater Los Angeles Healthcare System
$0
Attributed
$0
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $0 · FY2022–25$1$1$1$0$0
'22
'23
'24
'25
Funding mix
By agency
VA$0 · 2
By mechanism
I01$0 · 2
Top collaborators
No co-investigators on record.
Most similar at Va Greater Los Angeles Healthcare System
Same institution · by research overlap
- Hidekazu Tsukamoto$41,189,571
Others in their field
Other Rising Stars on “Mediating”
- Julia Louise Moore Vogel · Scripps Research Institute, The$32,252,685
- Suma Babu · Massachusetts General Hospital$25,538,716
- Sabrina Paganoni · Massachusetts General Hospital$25,538,716
- Supriya Menezes · The Emmes Company, Llc$25,277,032
- Cathie Snyder · Rho Federal Systems Division, Inc.$13,500,724
- Daofeng Li · Salk Institute For Biological Studies$9,887,266
Research focus
MediatingPd-1 BlockadeImmune Checkpoint BlockadeMalignant NeoplasmsMouse ModelPatient SubsetsDiagnosisImmuneChromatinMalignant Neoplasm Of LungMilitary PersonnelMorbidity - Disease RateAntitumor EffectMutationAdvanced Malignant NeoplasmDesignCellsGenomicsCancer CellAnti-Pd1 AntibodiesImmunotherapyInhibitorComplexPlay
Grant awards (5)
Role of ATRX, a chromatin remodeler, in immunotherapy response$0
I01 · FY2025 · VA · contact PI
Role of ATRX, a chromatin remodeler, in immunotherapy response$0
I01 · FY2024 · VA · contact PI
Phase Ib/II study of safety and efficacy of EZH2 inhibitor, tulmimetostat, and PD-1 blockade for treatment of advanced non-small cell lung cancer$0
I01 · FY2023 · VA · contact PI
Role of ATRX, a chromatin remodeler, in immunotherapy response$0
I01 · FY2023 · VA · contact PI
Role of ATRX, a chromatin remodeler, in immunotherapy response$0
I01 · FY2022 · VA · contact PI